WILKES UNIVERSITY NSG 533 ADVANCED
PHARMACOLOGY EXAM 1 – 100 PRACTICE
QUESTIONS WITH ANSWERS &
RATIONALES (VERIFIED ANSWERS) |
ALREADY GRADED A+ | INSTANT
DOWNLOAD PDF
Core Domains
• Pharmacokinetics: Absorption, Distribution, Metabolism, and
Excretion
• Pharmacodynamics: Receptor Theory, Agonists, and Antagonists
• Pharmacogenomics and Individualized Drug Therapy
• Drug Interactions and Cytochrome P450 Enzyme System
• Prescriptive Authority, Legal, and Ethical Considerations
• Special Populations: Geriatric, Pediatric, and Pregnancy Considerations
• Autonomic Nervous System Pharmacology
• Therapeutic Index, Safety, and Monitoring Parameters
Introduction
This examination assesses the foundational pharmacologic knowledge required
for advanced nursing practice, focusing on the principles that govern drug
movement, drug action, and individual variation in drug response. It evaluates
understanding of pharmacokinetic processes, pharmacodynamic mechanisms,
pharmacogenomic influences, and the regulatory framework for prescriptive
authority. Questions are structured in multiple-choice and scenario-based
formats to emphasize clinical application and decision-making. A strong
,emphasis is placed on safe prescribing practices, drug interactions, and special
population considerations. Candidates must demonstrate the ability to apply
these principles to real-world patient care scenarios.
SECTION ONE: QUESTIONS 1–100
1. Which of the following best defines pharmacokinetics?
A. The study of how drugs produce their therapeutic effects
B. The study of drug movement throughout the body, including absorption,
distribution, metabolism, and excretion
C. The study of how genetic variations affect drug response
D. The study of drug-receptor interactions
B
RATIONALE: Pharmacokinetics is the study of drug movement
throughout the body, encompassing the four basic processes of absorption,
distribution, metabolism, and excretion (ADME). Option A describes
pharmacodynamics, Option C describes pharmacogenomics, and Option D
describes receptor theory.
2. Which of the following are the three most important properties of an
ideal drug?
A. Potent, Fast-acting, Inexpensive
B. Effective, Safe, Selective
C. Absorbable, Distributable, Excretable
D. Agonist, Antagonist, Partial agonist
B
RATIONALE: The three most important properties of drugs are that they
must be effective (elicits the response for which it is given), safe (cannot
produce harmful effects even at high doses), and selective (elicits only the
response for which it is given).
,3. Prescriptive authority for nurse practitioners includes which two
components?
A. The right to prescribe controlled substances and the right to dispense
medications
B. The right to prescribe independently and the right to prescribe without
limitation
C. The right to prescribe generically and the right to prescribe brand-name
drugs
D. The right to prescribe in all states and the right to prescribe across state
lines
B
RATIONALE: Prescriptive authority is the legal right to prescribe drugs
and includes two components: the right to prescribe independently and the
right to prescribe without limitation, although state and federal regulations
may impose restrictions.
4. A patient is prescribed an oral medication that undergoes extensive
first-pass metabolism. What is the clinical implication of this effect?
A. The drug has increased bioavailability because hepatic enzymes enhance
its active form
B. A significant portion of the oral dose is metabolized by the liver before
reaching systemic circulation, reducing bioavailability
C. The drug is primarily excreted unchanged by the kidneys, requiring dose
adjustment in renal impairment
D. The drug crosses the blood-brain barrier more efficiently due to hepatic
biotransformation
B
RATIONALE: First-pass metabolism occurs when orally administered
drugs are absorbed through the GI tract and carried by the portal vein directly
to the liver, where they undergo significant metabolism before reaching
, systemic circulation. This reduces the bioavailability of the drug. Drugs with
high first-pass metabolism may require higher oral doses or alternative routes.
5. A patient with advanced liver cirrhosis is prescribed a medication
that is 98% protein-bound. Which pharmacokinetic change is most
likely to occur?
A. Increased free drug fraction due to decreased albumin production,
increasing the risk of drug toxicity
B. Decreased free drug fraction due to increased plasma protein synthesis
C. No change in drug distribution because protein binding is unaffected by
liver disease
D. Increased volume of distribution due to enhanced tissue binding
A
RATIONALE: In advanced liver cirrhosis, hepatic synthesis of albumin is
significantly reduced. With less albumin available, the free (unbound)
fraction of highly protein-bound drugs increases. The free drug is
pharmacologically active, so this increases the risk of drug toxicity at standard
doses.
6. Which pharmacokinetic process is primarily affected by a patient's
serum albumin levels?
A. Metabolism
B. Absorption
C. Distribution
D. Excretion
C
RATIONALE: Distribution involves the transport of a drug by the
bloodstream to its site of action. Many drugs bind to plasma proteins like
albumin, and only the unbound portion is pharmacologically active. If
albumin levels are low, the concentration of free drug increases, potentially
leading to toxicity.
PHARMACOLOGY EXAM 1 – 100 PRACTICE
QUESTIONS WITH ANSWERS &
RATIONALES (VERIFIED ANSWERS) |
ALREADY GRADED A+ | INSTANT
DOWNLOAD PDF
Core Domains
• Pharmacokinetics: Absorption, Distribution, Metabolism, and
Excretion
• Pharmacodynamics: Receptor Theory, Agonists, and Antagonists
• Pharmacogenomics and Individualized Drug Therapy
• Drug Interactions and Cytochrome P450 Enzyme System
• Prescriptive Authority, Legal, and Ethical Considerations
• Special Populations: Geriatric, Pediatric, and Pregnancy Considerations
• Autonomic Nervous System Pharmacology
• Therapeutic Index, Safety, and Monitoring Parameters
Introduction
This examination assesses the foundational pharmacologic knowledge required
for advanced nursing practice, focusing on the principles that govern drug
movement, drug action, and individual variation in drug response. It evaluates
understanding of pharmacokinetic processes, pharmacodynamic mechanisms,
pharmacogenomic influences, and the regulatory framework for prescriptive
authority. Questions are structured in multiple-choice and scenario-based
formats to emphasize clinical application and decision-making. A strong
,emphasis is placed on safe prescribing practices, drug interactions, and special
population considerations. Candidates must demonstrate the ability to apply
these principles to real-world patient care scenarios.
SECTION ONE: QUESTIONS 1–100
1. Which of the following best defines pharmacokinetics?
A. The study of how drugs produce their therapeutic effects
B. The study of drug movement throughout the body, including absorption,
distribution, metabolism, and excretion
C. The study of how genetic variations affect drug response
D. The study of drug-receptor interactions
B
RATIONALE: Pharmacokinetics is the study of drug movement
throughout the body, encompassing the four basic processes of absorption,
distribution, metabolism, and excretion (ADME). Option A describes
pharmacodynamics, Option C describes pharmacogenomics, and Option D
describes receptor theory.
2. Which of the following are the three most important properties of an
ideal drug?
A. Potent, Fast-acting, Inexpensive
B. Effective, Safe, Selective
C. Absorbable, Distributable, Excretable
D. Agonist, Antagonist, Partial agonist
B
RATIONALE: The three most important properties of drugs are that they
must be effective (elicits the response for which it is given), safe (cannot
produce harmful effects even at high doses), and selective (elicits only the
response for which it is given).
,3. Prescriptive authority for nurse practitioners includes which two
components?
A. The right to prescribe controlled substances and the right to dispense
medications
B. The right to prescribe independently and the right to prescribe without
limitation
C. The right to prescribe generically and the right to prescribe brand-name
drugs
D. The right to prescribe in all states and the right to prescribe across state
lines
B
RATIONALE: Prescriptive authority is the legal right to prescribe drugs
and includes two components: the right to prescribe independently and the
right to prescribe without limitation, although state and federal regulations
may impose restrictions.
4. A patient is prescribed an oral medication that undergoes extensive
first-pass metabolism. What is the clinical implication of this effect?
A. The drug has increased bioavailability because hepatic enzymes enhance
its active form
B. A significant portion of the oral dose is metabolized by the liver before
reaching systemic circulation, reducing bioavailability
C. The drug is primarily excreted unchanged by the kidneys, requiring dose
adjustment in renal impairment
D. The drug crosses the blood-brain barrier more efficiently due to hepatic
biotransformation
B
RATIONALE: First-pass metabolism occurs when orally administered
drugs are absorbed through the GI tract and carried by the portal vein directly
to the liver, where they undergo significant metabolism before reaching
, systemic circulation. This reduces the bioavailability of the drug. Drugs with
high first-pass metabolism may require higher oral doses or alternative routes.
5. A patient with advanced liver cirrhosis is prescribed a medication
that is 98% protein-bound. Which pharmacokinetic change is most
likely to occur?
A. Increased free drug fraction due to decreased albumin production,
increasing the risk of drug toxicity
B. Decreased free drug fraction due to increased plasma protein synthesis
C. No change in drug distribution because protein binding is unaffected by
liver disease
D. Increased volume of distribution due to enhanced tissue binding
A
RATIONALE: In advanced liver cirrhosis, hepatic synthesis of albumin is
significantly reduced. With less albumin available, the free (unbound)
fraction of highly protein-bound drugs increases. The free drug is
pharmacologically active, so this increases the risk of drug toxicity at standard
doses.
6. Which pharmacokinetic process is primarily affected by a patient's
serum albumin levels?
A. Metabolism
B. Absorption
C. Distribution
D. Excretion
C
RATIONALE: Distribution involves the transport of a drug by the
bloodstream to its site of action. Many drugs bind to plasma proteins like
albumin, and only the unbound portion is pharmacologically active. If
albumin levels are low, the concentration of free drug increases, potentially
leading to toxicity.
